Most recent research investigating cancer-associated lymphangiogenesis has focused on vascular endothelial growth factor (VEGF) family members, which can interact with the receptor VEGFR-3 on lymphatic endothelial cells [14]. The gene discussed is VEGFA; the disease is cancer.